Biomarker Predicts Clinical Outcome of IBD Therapy in Autism– Arthur Krigsman, MD @Synchrony2020

2) Arthur Krigsman, MD - Digestive system problems in children on the autism spectrumПодробнее

Arthur Krigsman, MD- Synchrony 2019Подробнее

IBD 2021 Webinar: US IBD Health Outcomes Consortium – Real World Approach to Biomarkers in IBDПодробнее

IBD Webinar 2021: Biomarker Development: Opportunities in Inflammatory BowelПодробнее

ASD: Improvements Following Treatment of Enterocolitis - A Krigsman MD, S Walker PhD @Synchrony2022Подробнее

Role of diagnostic and therapeutic biomarkers in pediatric IBDПодробнее

Autism Biomarkers Consortium for Clinical Trials - James McPartland PhD, Yale @Synchrony2020Подробнее

BRAIN Talk with Dr Arthur Krigsman, MD & Dr Stephen Walker, PhDПодробнее

Treatment of ASD- Associated Enterocolitis - A Krigsman MD & S Walker PhD @Synchrony2021Подробнее

What matters most in IBD? Part 3/7Подробнее

What matters most in IBD? Part 2/7Подробнее

IBD 2021 Webinar: Microbiome Based BiomarkersПодробнее

EEG Biomarkers for Clinical Trials in Autism Spectrum DisorderПодробнее

Calprotectin in Inflammatory Bowel Disease | Serum | Eliminating the need for stool samplesПодробнее

The Case for Autistic Enterocolitis - Dr Arthur KrigsmanПодробнее

What matters most in IBD? Part 7/7Подробнее

IBD Webinar 2021: Panel 2Подробнее

Potential for prevention of developmental disorders including autism -E Quadros, SUNY @Synchrony2020Подробнее